ENDOCRINE SOCIETY DEVELOPMENT
Board
1 director, last change in 2024Sole director (not named in the articles)
in office according to the deed of 02-02-2024
term without a fixed end
earlier manager, until 02-02-2024
listed in the 2025 annual accounts, filed on 30-04-2026
Mandates through the years
1 name, the dashed line is todaySophie BROCHIER
Sole director (not named in the articles)
Sole director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- Sophie BROCHIER
- Sole director (not named in the articles), since before 30-09-2021
- Manager, until 02-02-2024
Control
100%
This company
ENDOCRINE SOCIETY DEVELOPMENT
Equity €644,152
Profit €151,962 in 2025
Capital
- Contribution
- €12,400
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- SOPHIE BROCHIER
Source: shareholder structure in its own accounts
Articles of association
deed of 02-02-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Nominatives, personnes physiques titre docteur en médecine ou sociétés professionnelles médecins à personnalité juridique dont statuts…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Saturday of November at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor